Target intelligence / Profile preview

Double homeobox 4 like 14 (pseudogene) (DUX4L14)

Target: DUX4L14
Molecular classification: Other (pseudogene), DUX family pseudogene

Overview

Double homeobox 4 like 14 (DUX4L14) is a pseudogene that shares sequence similarity with DUX4, a transcription factor implicated in embryonic development and diseases such as facioscapulohumeral muscular dystrophy (FSHD)[2]. Unlike DUX4, DUX4L14 does not encode a protein and has no established physiological, pathological, or therapeutic relevance. Its nomenclature and sequence may lead to confusion with DUX4, a gene of medical and biological importance, but DUX4L14 itself is not considered a therapeutic target and is not functionally characterized in the context of human disease, signaling, or pharmacology[2].

Other names: Double homeobox, 4 pseudogeneDUX4L14double homeobox 4 like 14 (pseudogene)

Beyond the preview

Go deeper on Double homeobox 4 like 14 (pseudogene) (DUX4L14).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Double homeobox 4 like 14 (pseudogene) (DUX4L14).

Explore the full profile